Funding and Partners
|National Health and Medical Research Council of Australia:
The QSkin study is supported primarily through a Clinical Trials and Cohort Studies (CTCS) Grant from the NHMRC.
Funded by an NHMRC CTCS grant 2020–2024.
|Melanoma Patients Australia:
We wish to acknowledge the assistance of Melanoma Patients Australia, their members and families, in overseeing the development of the QSkin study documents.